Janney Montgomery Scott’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,331
Closed -$403K 2769
2025
Q4
$403K Sell
1,331
-430
-24% -$134K ﹤0.01% 2356
2025
Q3
$494K Buy
1,761
+885
+101% +$241K ﹤0.01% 2150
2025
Q2
$211K Sell
876
-300
-26% -$70.9K ﹤0.01% 2537
2025
Q1
$286K Sell
1,176
-2,825
-71% -$850K ﹤0.01% 2329
2024
Q4
$1.31M Sell
4,001
-130
-3% -$44.1K ﹤0.01% 1387
2024
Q3
$1.38M Sell
4,131
-135
-3% -$42.9K ﹤0.01% 1325
2024
Q2
$1.17M Sell
4,266
-458
-10% -$133K ﹤0.01% 1361
2024
Q1
$1.63M Buy
4,724
+680
+17% +$224K ﹤0.01% 1252
2023
Q4
$1.3M Sell
4,044
-699
-15% -$219K ﹤0.01% 1307
2023
Q3
$1.7M Buy
4,743
+2,577
+119% +$994K 0.01% 1085
2023
Q2
$821K Buy
+2,166
New +$881K ﹤0.01% 1538
2023
Q1
Sell
-1,985
Closed -$835K 2556
2022
Q4
$835K Buy
1,985
+352
+22% +$142K ﹤0.01% 1462
2022
Q3
$681K Buy
+1,633
New +$814K ﹤0.01% 1503
2021
Q1
Sell
-925
Closed -$539K 2243
2020
Q4
$539K Buy
925
+484
+110% +$276K ﹤0.01% 1525
2020
Q3
$227K Buy
+441
New +$223K ﹤0.01% 1843

Other funds holding BIO

Janney Montgomery Scott's BIO Position: Q1 2026 in Review

Janney Montgomery Scott sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2026, closing a stake of 1,331 shares — an estimated $403K sold.

Janney Montgomery Scott first reported a position in BIO in Q3 2020 and held it in 15 quarters. The position peaked at $1.7M in Q3 2023. 395 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • Janney Montgomery Scott reported no remaining Bio-Rad Laboratories Class A position as of Q1 2026 after selling out during the quarter.
  • Janney Montgomery Scott sold 1,331 Bio-Rad Laboratories Class A shares in Q1 2026, an estimated $403K.
  • Janney Montgomery Scott first reported a position in Bio-Rad Laboratories Class A in Q3 2020 and held it in 15 quarters.
  • Janney Montgomery Scott's Bio-Rad Laboratories Class A position peaked at $1.7M in Q3 2023.
  • 395 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.